City of Hope leads first U.S. clinical trial testing efficacy of delivering chemotherapy into the abdomen via a fine sprayAugust 11, 2020
The experimental PIPAC treatment may extend the lives of people with advanced ovarian, uterine, gastric and colorectal cancers whose current options are only local disease control and palliative care.
City of Hope’s Music, Film & Entertainment Industry group to launch high-end virtual auction series offering remarkable music memorabilia and unique experiencesAugust 3, 2020
City of Hope announced today that it will launch a high-end weekly virtual auction series in partnership with Charitybuzz.
Based on that research, new drug combinations aim to intercept cancer development.
Physician-scientists are using one of the world’s most comprehensive genomic analysis tools to determine whether targeted therapy or immunotherapy has the best chance of working for each individual patient.
City of Hope researchers identify mechanism that may lead to metabolic memory and sustained diabetes complicationsJuly 20, 2020
New data show how early episodes of hyperglycemia can have long-term effects.
Findings could improve personalized medicine for cancer patients.
City of Hope scientists demonstrate that the cancer inhibitors they’re developing could destroy acute myeloid leukemia and tumors from brain, pancreatic and breast cancers.
Glenn D. Steele, Jr., M.D., Ph.D., renowned health care leader and innovator, named chair of City of Hope Board of DirectorsJune 15, 2020
Steele, former president/chief executive officer of Geisinger Health System, will lead the center’s board of directors.
City of Hope signs licensing agreement with Scopus BioPharma Inc. to develop novel, targeted immuno-oncology gene therapyJune 11, 2020
A phase 1 clinical trial using the STAT 3 inhibitor is expected to commence at City of Hope later this year.
These important proof-of-concept studies could one day lead to new real-time diagnostic imaging techniques and the identification of genomic biomarkers that predict treatment results – innovations that will improve health outcomes for cancer patients